Transcription MRI: A new view of the living brain

Neuroscientist

Volumn 14, Issue 5, 2008, Pages 503-520

  Liu, Philip K ^a   Mandeville, Joseph B ^a   Dai, Guangping ^a   Jenkins, Bruce G ^a   Kim, Young R ^a   Liu, Christina H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Drug abuse; Immediate early gene; Molecular genetics; Transcription MRI

Indexed keywords

AMPHETAMINE; BETA ACTIN; COMPLEMENTARY DNA; CONTRAST MEDIUM; FERRIC FERROCYANIDE; IRON OXIDE; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE; PROTEIN C FOS; SMALL INTERFERING RNA; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

BRAIN CORTEX; BRAIN REGION; DRUG MECHANISM; GENE ACTIVITY; GENE TARGETING; GENETIC TRANSCRIPTION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFORMATION PROCESSING; LIMBIC CORTEX; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEIC ACID PROBE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOSIS; QUANTITATIVE ANALYSIS; REVIEW;

BRAIN; BRAIN CHEMISTRY; BRAIN MAPPING; CONTRAST MEDIA; GENE TARGETING; HUMANS; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; OLIGONUCLEOTIDE PROBES; TRANSCRIPTION, GENETIC;

EID: 52449123447     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858407309746     Document Type: Review

References (61)

1. Allport JR, Weissleder R. 2001. In vivo imaging of gene and cell therapies. Exp Hematol 29: 1237-46.
2. An G., Lin TN, Liu JS, Xue JJ, He YY, Hsu CY 1993. Expression of c-fos and c-jun family genes after focal cerebral ischemia. Ann Neurol 33: 457-64.
3. Artemov D., Mori N., Okollie B., Bhujwalla ZM 2003. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn Reson Med 49: 403-8.
4. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM 1995. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 34: 555-66.
5. Bulte JW, Douglas T., Witwer B., Zhang SC, Strable E., Lewis BK, and others. 2001. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 19: 1141-7.
6. Bulte JW, Kraitchman DL 2004. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17: 484-99.
7. Bulte JW, Zhang S., van Gelderen P., Herynek V., Jordan EK, Duncan ID, and others. 1999. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A 96: 15256-61.
8. Cui J., Holmes EH, Liu PK 1999. Oxidative damage to the c-fos gene and reduction of its transcription after focal cerebral ischemia. J Neurochem 73: 1164-74.
9. Cui JK, Hsu CY, Liu PK 1999. Suppression of postischemic hippocampal nerve growth factor expression by a c-fos antisense oligodeoxynucleotide. J Neurosci 19: 1335-44.
10. Cui J., Liu PK 2001. Neuronal NOS inhibitor that reduces oxidative DNA lesions and neuronal sensitivity increases the expression of intact c-fos transcripts after brain injury. J Biomed Sci 8: 336-41.
11. Ehrlich ME, Sommer J., Canas E., Unterwald EM 2002. Periadolescent mice show enhanced DeltaFosB upregulation in response to cocaine and amphetamine. J Neurosci 22: 9155-9.
12. Funovics MA, Kapeller B., Hoeller C., Su HS, Kunstfeld R., Puig S., and others. 2004. MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents. Magn Reson Imaging 22: 843-50.
13. Gamper HB, Reed MW, Cox T., Virosco JS, Adams AD, Gall AA, and others. 1993. Facile preparation of nuclease resistant 3′ modified oligodeoxynucleotides. Nucleic Acids Res 21: 145-50.
14. Grimm J., Perez JM, Josephson L., Weissleder R. 2004. Novel nanosensors for rapid analysis of telomerase activity. Cancer Res 64: 639-43.
15. Hebb MO, Robertson HA 1997. End-capped antisense oligodeoxynucleotides effectively inhibit gene expression in vivo and offer a low-toxicity alternative to fully modified phosphorothioate oligodeoxynucleotides. Brain Res Mol Brain Res 47: 223-8.
16. Hoehn M., Kustermann E., Blunk J., Wiedermann D., Trapp T., Wecker S., and others. 2002. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 99: 16267-72.
17. Hope B., Kosofsky B., Hyman SE, Nestler EJ 1992. Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc Natl Acad Sci U S A 89: 5764-8.
18. Hope BT, Nye HE, Kelz MB, Self DW, Iadarola MJ, Nakabeppu Y., and others. 1994. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13: 1235-44.
19. Ichikawa T., Hogemann D., Saeki Y., Tyminski E., Terada K., Weissleder R., and others. 2002. MRI of transgene expression: correlation to therapeutic gene expression. Neoplasia 4: 523-30.
20. Jenkins BG, Sanchez-Pernaute R., Brownell AL, Chen YC, Isacson O. 2004. Mapping dopamine function in primates using pharmacologic magnetic resonance imaging. J Neurosci 24: 9553-60.
21. Kelz MB, Chen J., Carlezon WA Jr, Whisler K., Gilden L., Beckmann AM, and others. 1999. Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature 401: 272-6.
22. Kim EE 2003. Targeted molecular imaging. Korean J Radiol 4: 201-10.
23. Lee HJ, Boado RJ, Braasch DA, Corey DR, Pardridge WM 2002. Imaging gene expression in the brain in vivo in a transgenic mouse model of Huntington's disease with an antisense radiopharmaceutical and drug-targeting technology. J Nucl Med 43: 948-56.
24. Lind K., Kresse M., Debus NP, Muller RH 2002. A novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphography: comparison of physicochemical properties and the in vivo behaviour. J Drug Target 10: 221-30.
25. Liu CH, D'Arceuil HE, de Crespigny AJ 2004. Direct CSF injection of MnCl(2) for dynamic manganese-enhanced MRI. Magn Reson Med 51: 978-87.
26. Liu CH, Huang S., Cui J., Kim YR, Farrar CT, Moskowitz MA, and others. 2007. MR contrast probes that trace gene transcripts for cerebral ischemia in live animals. Faseb J 21: 3004-15.
27. Liu CH, Huang S., Kim YR, Rosen BR, Liu PK 2007. Forebrain ischemia-reperfusion simulating cardiac arrest in mice induces edema and DNA fragmentation in the brain. Mol Imaging 6: 156-70.
28. Liu CH, Kim YR, Ren JQ, Eichler F., Rosen BR, Liu PK 2007. Imaging cerebral gene transcripts in live animals. J Neurosci 27: 713-22.
29. Liu PK, Salminen A., He YY, Jiang MH, Xue JJ, Liu JS, and others. 1994. Suppression of ischemia-induced fos expression and AP-1 activity by an antisense oligodeoxynucleotide to c-fos mRNA. Ann Neurol 36: 566-76.
30. Louie AY, Huber MM, Ahrens ET, Rothbacher U., Moats R., Jacobs RE, and others. 2000. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 18: 321-5.
31. Mandeville JB, Moore J., Chesler DA, Garrido L., Weissleder R., Weisskoff RM 1997. Dynamic liver imaging with iron oxide agents: effects of size and biodistribution on contrast. Magn Reson Med 37: 885-90.
32. Massoud TF, Gambhir SS 2003. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17: 545-80.
33. Medarova Z., Pham W., Farrar C., Petkova V., Moore A. 2007. In vivo imaging of siRNA delivery and silencing in tumors. Nat Med 13: 372-7.
34. Misgeld T., Kerschensteiner M. 2006. In vivo imaging of the diseased nervous system. Nat Rev Neurosci 7: 449-63.
35. Moore A., Medarova Z., Potthast A., Dai G. 2004. In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe. Cancer Res 64: 1821-7.
36. Nelson AL, Algon SA, Munasinghe J., Graves O., Goumnerova L., Burstein D., and others. 2003. Magnetic resonance imaging of patched heterozygous and xenografted mouse brain tumors. J Neurooncol 62: 259-67.
37. Nestler EJ, Barrot M., Self DW 2001. DeltaFosB: a sustained molecular switch for addiction. Proc Natl Acad Sci U S A 98: 11042-6.
38. Nielsen FC, Wang E., Gammeltoft S. 1991. Receptor binding, endocytosis, and mitogenesis of insulin-like growth factors I and II in fetal rat brain neurons. J Neurochem 56: 12-21.
39. Oshiro EM, Viola JJ, Oldfield EH, Walbridge S., Bacher J., Frank JA, and others. 1995. Toxicity studies and distribution dynamics of retroviral vectors following intrathecal administration of retroviral vector-producer cells. Cancer Gene Ther 2: 87-95.
40. Pardridge WM, Boado RJ 1991. Enhanced cellular uptake of biotinylated antisense oligonucleotide or peptide mediated by avidin, a cationic protein. FEBS Lett 288: 30-2.
41. Pautler RG, Fraser SE 2003. The year(s) of the contrast agent-micro-MRI in the new millennium. Curr Opin Immunol 15: 385-92.
42. Perez JM, Josephson L., O'Loughlin T., Hogemann D., Weissleder R. 2002. Magnetic relaxation switches capable of sensing molecular interactions. Nat Biotechnol 20: 816-20.
43. Rainov NG, Zimmer C., Chase M., Kramm CM, Chiocca EA, Weissleder R., and others. 1995. Selective uptake of viral and monocrystalline particles delivered intra-arterially to experimental brain neoplasms. Hum Gene Ther 6: 1543-52.
44. Reynolds F., O'Loughlin T., Weissleder R., Josephson L. 2005. Method of determining nanoparticle core weight. Anal Chem 77: 814-7.
45. Sagar SM, Sharp FR, Curran T. 1988. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240: 1328-31.
46. Schellenberger EA, Weissleder R., Josephson L. 2004. Optimal modification of annexin V with fluorescent dyes. Chembiochem 5: 271-4.
47. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD 1998. How cells respond to interferons. Annu Rev Biochem 67: 227-64.
48. Stroh A., Zimmer C., Gutzeit C., Jakstadt M., Marschinke F., Jung T., and others. 2004. Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. Free Radic Biol Med 36: 976-84.
49. Su W., Mishra R., Pfeuffer J., Wiesmuller KH, Ugurbil K., Engelmann J. 2007. Synthesis and cellular uptake of a MR contrast agent coupled to an antisense peptide nucleic acid-cell-penetrating peptide conjugate. Contrast Media Mol Imaging 2: 42-9.
50. Szklarczyk A., Kaczmarek L. 1995. Antisense oligodeoxyribonucleotides: stability and distribution after intracerebral injection into rat brain. J Neurosci Methods 60: 181-7.
51. Thompson PM, Hayashi KM, de Zubicaray G., Janke AL, Rose SE, Semple J., and others. 2003. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 23: 994-1005.
52. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y., and others. 2004. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 24: 6028-36.
53. Ujike H. 2002. Stimulant-induced psychosis and schizophrenia: the role of sensitization. Curr Psychiatry Rep 4: 177-84.
54. van Everdingen KJ, Enochs WS, Bhide PG, Nossiff N., Papisov M., Bogdanov A. Jr, and others. 1994. Determinants of in vivo MR imaging of slow axonal transport. Radiology 193: 485-91.
55. Weisskoff RM, Zuo CS, Boxerman JL, Rosen BR 1994. Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med 31: 601-10.
56. Whitesell L., Geselowitz D., Chavany C., Fahmy B., Walbridge S., Alger JR, and others. 1993. Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system. Proc Natl Acad Sci U S A 90: 4665-9.
57. Yamazaki T., Selkoe DJ, Koo EH 1995. Trafficking of cell surface beta-amyloid precursor protein: retrograde and transcytotic transport in cultured neurons. J Cell Biol 129: 431-42.
58. Zhang Y., Widmayer MA, Zhang B., Cui JK, Baskin DS 1999. Suppression of post-ischemic-induced fos protein expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage. Brain Res 832: 112-7.
59. Zhang Y., Zhang YF, Bryant J., Charles A., Boado RJ, Pardridge WM 2004. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin Cancer Res 10: 3667-77.
60. Zhao M., Beauregard DA, Loizou L., Davletov B., Brindle KM 2001. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med 7: 1241-4.
61. Zimmer C., Weissleder R., O'Connor D., LaPointe L., Brady TJ, Enochs WS 1995. Cerebral iron oxide distribution: in vivo mapping with MR imaging. Radiology 196: 521-7.